PCI 7 November 2023, 15:44
Temax_Krautz
Owen Mumford 12 January 2022, 17:40

Current Edition

Nasal & Pulmonary Drug Development
Staubli 11 March 2024, 13:59
Catalent: Mon 28 October 2024, 13:21
Novo Nordisk 20 March 2024, 11:21
Schott: Tue 17 September 2024, 10:51
Biosynth: Fri 4 October 2024, 10:42
How Modular Passive Pharma Packaging Systems Enable Strategically Refined COVID-19 Vaccine Shipping Regimes
Volume 12 Issue 4

How Modular Passive Pharma Packaging Systems Enable Strategically Refined COVID-19 Vaccine Shipping Regimes

What policies and processes should be adopted for the optimal cold chain management of vaccines. This task is more immense, complex and time-critical than ever befor...
Continue Reading →
Brexit White Paper
Volume 12 Issue 4

Brexit White Paper

The UK formally left the EU on 31st January 2020 and the transition period, as set out in the withdrawal agreement, will come to an end on 31st December 2020. During...
Continue Reading →
Truth Matters: Why Science Journalism Has Never Been So Important
Volume 12 Issue 4

Truth Matters: Why Science Journalism Has Never Been So Important

Although acknowledged as benefiting society, science is unfortunately conducted and consumed by a relatively small number of people who are often thought of as the “...
Continue Reading →
Putting Translation Central to the MDR Shift
Volume 12 Issue 4

Putting Translation Central to the MDR Shift

When it was announced that the Medical Device Directive (MDD) would be replaced by the Medical Device Regulation (MDR) several years ago, it triggered an enormous ta...
Continue Reading →
Clinical Requirements under EU MDR: Understanding the Changes
Volume 12 Issue 4

Clinical Requirements under EU MDR: Understanding the Changes

The European Medical Device Regulation 2017/745 (MDR) entered into force on 26th May 2017, bringing together requirements from the Medical Devices Directive (MDD, 93...
Continue Reading →
Optimising Device Design for New-generation Biologics
Volume 12 Issue 4

Optimising Device Design for New-generation Biologics

New waves of biological drugs may vastly improve treatment for many diseases, but not without adapted delivery devices for effective subcutaneous administration. Geo...
Continue Reading →
The Heightened Case for IDMP in the Light of COVID-19
Volume 12 Issue 4

The Heightened Case for IDMP in the Light of COVID-19

Once manufacturers, regulators and clinicians agree on consistent representation and description of the various attributes of a drug – the promise of ISO IDMP (Ident...
Continue Reading →
Critical Challenges and Potential Solutions to Optimise Downstream Bioprocessing Production
Volume 12 Issue 4

Critical Challenges and Potential Solutions to Optimise Downstream Bioprocessing Production

The term “optimise” is often applied to complex manufacturing, automation, and business processes. It suggests that the most efficient function of all the elements o...
Continue Reading →
The Rabbit and the Horseshoe Crab
Volume 12 Issue 4

The Rabbit and the Horseshoe Crab

The LAL method, which is the industry standard for the detection of gram-negative bacterial endotoxin, was preceded by the rabbit pyrogen test by about 30 years. To ...
Continue Reading →
SAE Media: Fri 25 October 2024, 10:33
PHARMAP: Mon 14 October 2024, 10.36
Automa: Mon 14 October 2024, 10:22
FujiFilm Skyscraper: 26th November 2024
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Stoelzle Skyscraper: 27th November 2024
LBBOHLE, Thu 20 April 2023, 17:23
Nipro 14 March 2024, 11:35
Novonordisk: Wed 17 July 2024, 13:49